Test Code TOBTA Tobramycin, Trough, Serum
Reporting Name
Tobramycin, Trough, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Monitoring adequate clearance of tobramycin near the end of a dosing cycle
Method Name
Immunoassay
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Draw blood no more than 30 minutes before next scheduled dose.
2. Serum gel tubes should be centrifuged within 2 hours of collection.
3. Red-top tubes should be centrifuged, and the serum aliquoted into a plastic vial within 2 hours of collection.
Specimen Type
SerumSpecimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Reject Due To
Gross hemolysis | Reject |
Reference Values
Therapeutic: <2.0 mcg/mL
Toxic: >2.0 mcg/mL
Interpretation
Goal levels depend on the type of infection being treated. Goal trough levels should be below 2.0 mcg/mL for conventional (nonpulse) dosing. Prolonged exposure to trough levels exceeding 2.0 mcg/mL may lead to toxicity.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
80200
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
TOBTA | Tobramycin, Trough, S | 4059-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
TOBTA | Tobramycin, Trough, S | 4059-2 |
Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.